Using PRO to identify risk symptoms for discontinuation of treatment for Bladder Cancer

Category Primary study
ConferenceQuality of Life Research
Year 2022
This article has no abstract
Epistemonikos ID: e1b4e9924b82bb13bdf7b0b72ab3710d0cd97e46
First added on: Apr 30, 2026